Synapse Biomedical Debuts Diaphragm Pacer, HDE-Cleared To Aid Breathing
This article was originally published in The Gray Sheet
Executive Summary
Synapse Biomedical will pursue expanded approval of its diaphragm pacing system to facilitate breathing in patients with Lou Gehrig's disease after gaining a humanitarian device exemption June 17 for use by ventilator-dependent spinal cord injury patients, according to the company